Featuring and interview with EASD President, Professor David Matthews.
Join us for an end-of-year review of the biggest trials of 2019, plus a detailed interview with Professor Matthews about key data, what the future may entail, and the debate surrounding the ESC 2019 guidelines.
References
This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.